Vape Industry Weekly: June Week 5 — Top 7 Stories

Quick Overview

This was a regulation-heavy week in the vape industry. Three major themes dominated: the UK disposable vape ban’s first anniversary confirmed what critics predicted — smoking rates went up, not down. The FDA moved to close the foreign manufacturer loophole targeting Chinese disposable imports. And the 2026 FIFA World Cup became a flashpoint for global nicotine policy, treating vaping the same as smoking across all venues. Meanwhile, Tucker Carlson’s ALP nicotine pouches announced European expansion, and a major scientific review reignited the cancer risk debate.

1. UK Disposable Vape Ban One Year Later: Smoking Rates Rose

The UK’s disposable vape ban hit its one-year mark, and the data is not kind to supporters. An ELFBAR/Opinium survey of 6,000 UK adults found that while 72% of daily vapers switched to reusable devices, 1 in 6 former disposable users returned to smoking or increased their cigarette consumption. UK smoking rates climbed from 14% in 2024 to 16% in 2026. A University of Bristol study published in PLOS Global Public Health confirmed that dual users are likely to smoke more after a ban. Meanwhile, 30% of respondents were aware of illegal vape sales in their area, and 1 in 4 vapers bought illicit products. The Netherlands is seeing similar patterns with flavor bans pushing users to the black market. We covered this in detail here.

2. FDA Proposes Oversight of Foreign Tobacco Manufacturers

The FDA proposed a rule requiring foreign tobacco product manufacturers to register their U.S.-bound facilities and list products, closing a regulatory gap that currently exempts overseas producers from requirements imposed on domestic companies. The rule targets unauthorized disposable e-cigarettes from Chinese manufacturers. If finalized, foreign facilities would become subject to FDA inspections, and manufacturers must maintain records for at least four years. Acting CTP Director Bret Koplow said the rule would help ensure all companies selling tobacco products in the U.S. operate under the same standards. Public comments are accepted through September 14. Read our full analysis.

3. ALP Nicotine Pouches Launch in Europe

ALP, the nicotine pouch brand backed by Tucker Carlson, announced European expansion starting July 2026. Online sales will launch in Britain, Ireland, Greece, Switzerland, and Romania in July, followed by the Czech Republic, Poland, Portugal, and Spain. The company signed a Lithuanian manufacturer to produce 20 million units in 2026 and 50 million in 2027. ALP also partnered with former UFC champion Conor McGregor for marketing. Grand View Research forecasts the European nicotine pouch market reaching over $6 billion by 2031, up from roughly $1.7 billion in 2024. Full story here.

4. FIFA World Cup 2026 Bans Vaping Alongside Smoking

FIFA banned both smoking and vaping throughout all official 2026 World Cup stadiums, fan festivals, and surrounding controlled areas across the U.S., Canada, and Mexico. Fans caught violating face removal, fines, and potential exclusion from future FIFA events. The policy treats combustible cigarettes and smoke-free nicotine products identically, ignoring evidence that vaping carries substantially lower risks. A UK Vape Club survey found 80% of regular vapers would consider buying illegal products while traveling if legal options are unavailable. Mexico’s aggressive anti-vaping policies and Thailand’s severe penalties (including jail time) compound the risk for traveling vapers. Our coverage.

5. Major Review: Vaping “Likely” Causes Lung and Oral Cancer

A peer-reviewed synthesis paper led by Prof. Bernard Stewart (UNSW) analyzed over 100 studies and concluded that nicotine-based e-cigarettes are “likely” to cause lung and oral cancers. Published in Carcinogenesis (Vol 47, bgag015), the paper reinterprets existing literature rather than presenting new primary data. The review identified multiple carcinogens in e-cigarette aerosol, including VOCs and metal heating coil byproducts. Harm reduction experts noted that no human epidemiological evidence of vaping-caused cancer exists to date, and the paper’s “likely” framing reflects a synthesis of animal, biomarker, and lab studies rather than direct human causation data. Our analysis.

6. 5th Circuit Backs FDA’s Block on Menthol Vape Marketing

The U.S. Court of Appeals for the Fifth Circuit upheld the FDA’s denial of marketing applications for menthol-flavored e-cigarette products from Triton Distribution and Vapetasia LLC. The court ruled the FDA reasonably concluded that the products’ potential benefits for adult smokers did not outweigh the risks of youth initiation. This reinforces the “appropriate for the protection of public health” standard under PMTA and suggests the FDA’s de facto flavor ban will continue to hold up in court. We covered this here.

7. Haypp Report: Quitting Smoking Motivates Nearly Half of Pouch Users

Haypp Group released its Nicotine Pouch and Oral Nicotine Report 2026, based on data from 172,000+ customers and a survey of 2,245 adult pouch users. 46% said quitting smoking or vaping was a reason they first tried pouches. 88% had previously used another nicotine product. The average age of first-time online pouch purchaser was 45, and adults aged 55-64 were the fastest-growing segment. Online age verification was recalled by 98% of users versus 75% in physical stores, a significant data point for regulators considering sales channel restrictions.

Weekly Trends & Analysis

The dominant pattern this week is clear: regulators worldwide are treating all nicotine products as a single problem, regardless of relative risk. The FIFA World Cup ban, the UK ban’s unintended consequences, and the FDA’s continued crackdown on flavors all point in the same direction. The harm reduction argument is losing ground to a zero-tolerance approach. The UNSW cancer review, despite its limitations (synthesis paper, not new human data), will be cited by policymakers as evidence that vaping is not a safe alternative. The counter-narrative: prohibition drives black markets and pushes people back to smoking — is supported by real-world data from the UK and Australia, but it’s not winning the policy debate. Watch for more states and countries to follow the “treat everything the same” approach.

What to Watch Next Week

The FDA’s foreign manufacturer oversight rule enters its public comment period. Expect industry pushback and potential congressional interest. The ALP European launch goes live in July. Watch for initial sales data and regulatory responses in target markets. The UNSW cancer review will likely generate follow-up commentary and rebuttals from THR advocates. And with the World Cup running through July. Expect more stories about vapers caught by the ban at stadiums and fan zones across the three host nations.